1. Home
  2. MWH vs HALO Comparison

MWH vs HALO Comparison

Compare MWH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MWH

SOLV Energy Inc. Class A Common Stock

N/A

Current Price

$31.72

Market Cap

8.2B

Sector

Industrials

ML Signal

N/A

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$69.65

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWH
HALO
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.8B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
MWH
HALO
Price
$31.72
$69.65
Analyst Decision
Strong Buy
Buy
Analyst Count
12
11
Target Price
$35.42
$78.64
AVG Volume (30 Days)
2.0M
1.5M
Earning Date
03-19-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
N/A
$151,862,000.00
Revenue This Year
$51.86
$28.24
Revenue Next Year
$14.78
$12.56
P/E Ratio
$50.60
$57.98
Revenue Growth
N/A
N/A
52 Week Low
$26.60
$51.06
52 Week High
$48.40
$82.22

Technical Indicators

Market Signals
Indicator
MWH
HALO
Relative Strength Index (RSI) 39.36 52.91
Support Level $27.16 $67.94
Resistance Level $48.40 $70.93
Average True Range (ATR) 2.18 2.00
MACD -0.70 0.07
Stochastic Oscillator 20.20 60.42

Price Performance

Historical Comparison
MWH
HALO

About MWH SOLV Energy Inc. Class A Common Stock

SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: